Search

everythinglearnresearchcommunity

for

Search:↓

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Ginseng extracts protect brain cells and reduce damage in diabetic rats.

Glycine reduces skin pigmentation by lowering melanin production.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Metformin may help treat neuroendocrine tumors.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Pioglitazone combined with metformin or spironolactone improves PCOS symptoms and insulin resistance.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Linagliptin slows down premature aging in certain mice.

Inhibiting plant sterols reduces grapevine pathogen reproduction.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

The hydrogel speeds up diabetic wound healing by adapting to glucose levels and releasing insulin.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Topical glycopyrrolate lotion helped reduce excessive sweating from eating in a diabetic man.